Tag: Auvi q

In 2024, the FDA approved Neffy, a needle-less nasal spray, as a new alternative for administering epinephrine. This development, alongside other market options, has provided a wider range of choices for people who need to carry this life-saving medication. Navigating what to use instead of an EpiPen involves considering device type, cost, features, and ease of use.

The FDA's approval of Neffy, the first needle-free epinephrine nasal spray, marked a significant milestone in anaphylaxis treatment for adults and children over 66 pounds in 2024. For decades, injectable devices like the EpiPen dominated the market, but patients now have more options addressing concerns about usability and needle aversion. Understanding these newer treatments is essential for anyone managing life-threatening allergies. So, what is the FDA approved alternative to the epi pen?